Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.
Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.
News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.
Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.
Dentsply Sirona (Nasdaq: XRAY) has announced the resignation of Chief Financial Officer Jorge Gomez, effective May 6, 2022. Gomez, who joined the company in 2019, will take on a CFO role at another public company. The firm is now beginning the search for his replacement. CEO Don Casey expressed gratitude for Gomez’s contributions, notably in enhancing the Finance and IT sectors and improving the company's ESG initiatives. Dentsply Sirona maintains its status as the largest manufacturer of dental products and technologies worldwide.
Dentsply Sirona (Nasdaq: XRAY) has appointed John P. Groetelaars to its Board of Directors, expanding the board from eleven to twelve members. Groetelaars brings over 30 years of experience in MedTech, including his role as former CEO of Hillrom, where he led a $3 billion revenue organization. His leadership in transforming business strategies and promoting diversity initiatives positions him as a valuable asset to the board. Dentsply Sirona aims to enhance patient care through innovative dental solutions with his guidance.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call on May 5, 2022, at 8:30 am ET to discuss its financial results. Investors can access a presentation on the company's website. The live webcast will also be available through the Investors section. Participants can join by dialing +1-877-370-7637 for domestic or +1-629-228-0723 for international calls, using Conference ID # 7888396. A replay will be accessible for one week post-call. Dentsply Sirona is a leading global manufacturer of dental products, known for its commitment to innovation and quality.
Dentsply Sirona, the world’s largest manufacturer of dental products, will participate in the Piper Sandler Virtual Dental Day. CEO Don Casey will lead a fireside chat on March 29, 2022, at 1:00 pm ET. The event will be accessible via a live webcast on the Dentsply Sirona Investors website. A replay will be available for 30 days post-discussion. Dentsply Sirona, listed on Nasdaq under the symbol XRAY, has a rich 135-year heritage in dental innovation, providing high-quality products to enhance patient care.
Dentsply Sirona (NASDAQ: XRAY) announced an accelerated share repurchase agreement totaling $150 million with Bank of America to repurchase its common stock. The initial delivery will be approximately 2.4 million shares, with final share count depending on the average stock prices during the valuation period. The ASR is expected to conclude by the end of Q2 2022, pending acceleration adjustments. This move aims to enhance shareholder value within Dentsply Sirona's current buyback authorization.
Dentsply Sirona reported strong FY21 results, with net sales of $4,251 million, a 27.2% increase year-over-year. Operating income rose to $622 million, and adjusted EPS reached $2.87, up 60.3%. However, Q4 sales were flat at $1,088 million, with adjusted EPS dropping 12.6% to $0.76. For FY22, the company forecasts organic sales growth of 4% to 5% and adjusted EPS between $3.05 and $3.25. CEO Don Casey emphasized their optimistic outlook based on a robust innovation pipeline and strategic partnerships.
Dentsply Sirona (Nasdaq: XRAY) is set to unveil a collaboration with Google Cloud and its new 3D printing solution, Primeprint, on March 4, during a virtual global event. This partnership aims to enhance digital dentistry by improving workflows for dentists and labs. Key principles include secure data sharing and high-quality 3D visualization. Primeprint represents a significant advancement in 3D printing technology for dental applications, offering automated processes and regulatory compliance for medical products. The innovations aim to empower dental professionals and improve patient care.
Dentsply Sirona (Nasdaq: XRAY) announced the appointment of Dr. Dorothea Wenzel to its Board of Directors, increasing the board size from ten to eleven members. Dr. Wenzel brings extensive experience from her previous role as Executive Vice President at Merck KGaA, enhancing the board's international perspective. Her background in healthcare and finance is expected to support Dentsply Sirona's vision to advance dentistry and improve oral health globally.
Dentsply Sirona, listed on Nasdaq under the symbol XRAY, announced an investor conference call and live webcast scheduled for February 28, 2022, at 8:30 am ET to discuss its financial results. Interested participants can access the live webcast on the company’s website. For those joining by phone, domestic calls can dial +1-877-370-7637, and international calls can use +1-629-228-0723 with Conference ID #1271213. A replay will be accessible on the company’s website and via dial-in for one week post-call.
Dentsply Sirona (Nasdaq: XRAY) announces its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 12, 2022, at 11:15 am ET. CEO Don Casey will present during this virtual event. Interested parties can access a live audio webcast and presentation materials on the Company’s investor website. A replay will be available for 30 days after the presentation. Dentsply Sirona is a leading manufacturer of dental products, providing innovative solutions to enhance patient care.
FAQ
What is the current stock price of Dentsply Sirona (XRAY)?
What is the market cap of Dentsply Sirona (XRAY)?
